New obesity drug candidates enter human testing
Disease control
Not yet recruiting
This early-stage trial will test two similar injectable drugs for obesity, called HUC2-676 and HUC2-676-R, in 40 healthy adults. Each person will receive a single dose of both drugs at different times to compare safety and how the body processes them. The study is not yet recruit…
Phase: PHASE1 • Sponsor: Huons Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC